GSK PLC AdrhedgedGSKHETF
13F holders, Q1 2026 (March 31)1holders
1new positions
1sold out
$77.00avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding GSK PLC Adrhedged (GSKH) in their 13F filings, unchanged from Q4 2025. 1 opened new positions and 1 sold out. The largest holder was JPMorgan Chase & Co. ($77).
- Company
- GSK PLC Adrhedged
- CUSIP
- 74016W874
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $77 |
| Exits | 1 | $4K |
All 13F filers, Q4 2025 → Q1 2026: 1 shares bought and 65 shares sold, net −64 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| JPMorgan Chase & Co. | 0.00% | New | 1 | $77 |
"% of holder's portfolio" is GSKH's weight in each manager's 13F, not the share of GSK PLC Adrhedged the manager owns.